Pacific Biosciences of California expands HiFi WGS and targeted panels to detect hidden cancer variants

Pacific Biosciences of California expands HiFi WGS and targeted panels to detect hidden cancer variants
Pacific Biosciences cancer genomics push

Pacific Biosciences of California is advancing cancer genomics with its HiFi whole genome sequencing (WGS) and targeted panel solutions.

The company emphasizes that its technology uncovers complex gene fusions and hidden genetic variants that traditional methods often miss. This approach aims to address the unpredictable and intricate nature of cancer biology, potentially improving diagnosis and treatment strategies for challenging cases.

Pacific Biosciences of California previously launched HiFi sequencing to provide detailed cancer variation data for researchers, according to a recent report. The company also unveiled PacBio HiFi technology that maps structural variants and novel isoforms in cancer genomics on a single platform, as outlined in a prior update. These moves highlight the firm’s recent efforts to expand its genomics solutions within cancer research.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.